AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
AXIM Biotechnologies's shares outstanding was 479M at Sep 30, 2023. For fiscal 2020 it was 110M, up 78.2% from the year before. The highest annual figure on record is 110M in fiscal 2020.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | 110M | +78.2% |
| FY2019 | Dec 31, 2019 | 62M | +8.1% |
| FY2018 | Dec 31, 2018 | 57M | +7.5% |
| FY2017 | Dec 31, 2017 | 53M | +27.7% |
| FY2016 | Dec 31, 2016 | 42M | +12.6% |
| FY2015 | Dec 31, 2015 | 37M | +12.3% |
| FY2014 | Dec 31, 2014 | 33M | 0.0% |
| FY2013 | Dec 31, 2013 | 33M | 0.0% |
| FY2012 | Dec 31, 2012 | 33M | +41.8% |
| FY2011 | Dec 31, 2011 | 23M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | 479M | +225.2% |
| Q2 FY2023 | Jun 30, 2023 | 226M | +69.3% |
| Q3 FY2022 | Sep 30, 2022 | 172M | +32.5% |
| Q2 FY2022 | Jun 30, 2022 | 155M | +23.1% |
| Q1 FY2022 | Mar 31, 2022 | 147M | +17.4% |
| Q3 FY2021 | Sep 30, 2021 | 134M | +8.2% |
| Q2 FY2021 | Jun 30, 2021 | 130M | +1.0% |
| Q1 FY2021 | Mar 31, 2021 | 126M | +67.8% |
| Q4 FY2020 | Dec 31, 2020 | 125M | +97.8% |
| Q3 FY2020 | Sep 30, 2020 | 123M | +97.6% |
| Q2 FY2020 | Jun 30, 2020 | 128M | +108.5% |
| Q1 FY2020 | Mar 31, 2020 | 75M | +24.6% |
| Q4 FY2019 | Dec 31, 2019 | 63M | -10.1% |
| Q3 FY2019 | Sep 30, 2019 | 62M | +7.8% |
| Q2 FY2019 | Jun 30, 2019 | 62M | +8.2% |
| Q1 FY2019 | Mar 31, 2019 | 60M | +9.5% |
| Q4 FY2018 | Dec 31, 2018 | 71M | +29.2% |
| Q3 FY2018 | Sep 30, 2018 | 58M | +8.3% |
| Q2 FY2018 | Jun 30, 2018 | 57M | +8.3% |
| Q1 FY2018 | Mar 31, 2018 | 55M | +4.8% |
| Q4 FY2017 | Dec 31, 2017 | 55M | +26.6% |
| Q3 FY2017 | Sep 30, 2017 | 54M | +20.7% |
| Q2 FY2017 | Jun 30, 2017 | 53M | +32.2% |
| Q1 FY2017 | Mar 31, 2017 | 53M | +32.2% |
| Q4 FY2016 | Dec 31, 2016 | 43M | +9.2% |
| Q3 FY2016 | Sep 30, 2016 | 44M | +12.5% |
| Q2 FY2016 | Jun 30, 2016 | 40M | +9.6% |
| Q1 FY2016 | Mar 31, 2016 | 40M | +20.3% |
| Q4 FY2015 | Dec 31, 2015 | 39M | +19.7% |
| Q3 FY2015 | Sep 30, 2015 | 39M | +19.4% |
| Q2 FY2015 | Jun 30, 2015 | 36M | – |
| Q1 FY2015 | Mar 31, 2015 | 33M | – |
| Q4 FY2014 | Dec 31, 2014 | 33M | – |
| Q3 FY2014 | Sep 30, 2014 | 33M | – |
See a number that looks wrong?